Sydnexis Inc.

Ophthalmology

Sydnexis Inc. is engaged in clinical research focused on myopia, with particular attention to childhood vision disorders and the progression of refractive error.

  • Myopia
  • Childhood vision disorders
  • Refractive error management

The sponsor’s research activity is centered on eye health and the clinical evaluation of treatments intended for pediatric patients with progressive myopia.

Pediatric medicine

Its clinical program includes research in children, reflecting an interest in conditions that affect visual development during early life.

  • Pediatric patients
  • Visual development
  • Early-onset eye disease

This area of interest aligns with studies designed to address the needs of school-age children living with progressive myopia.

Vision preservation

The sponsor’s therapeutic focus includes approaches intended to slow worsening eyesight and support long-term visual function in affected children.

  • Myopia progression
  • Visual function
  • Eye care intervention

Research in this domain reflects a commitment to interventions that address the clinical burden associated with advancing myopia.

Ocular safety and tolerability

Clinical interest also extends to the safety profile and tolerability of ophthalmic treatments used in children with myopia.

  • Ophthalmic solution safety
  • Tolerability in children
  • Eye treatment monitoring

This supports evaluation of therapies within the broader field of pediatric ophthalmology.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety and Effectiveness of SYD-101 Eye Drops with Atropine Sulfate Monohydrate for Treating Myopia in Children

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Austria Slovakia